Burke Medical Research Institute

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Burke Medical Research Institute sits in the top decile of US sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count).

11 total trials 2 currently recruiting 5 completed early-phase tilt top decile by trial count

Burke Medical Research Institute: 11 sponsored US clinical trials, 2 recruiting.

Burke Medical Research Institute sponsors 11 registered US clinical trials on ClinicalTrials.gov, 2 of them currently recruiting, and 5 completed. 2 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Cerebral Palsy, with 3 trials.

Top-decile sponsor footprint

Burke Medical Research Institute ranks in the top decile of sponsors by registered trial count (#1,226 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Open and recent trials

11 total, page 1 of 1

RECRUITING NA

Operant Conditioning of the Soleus Stretch Reflex in Adults With Cerebral Palsy

NCT05571033
RECRUITING NA

tDCS and Bimanual Therapy for Children With Hemiplegic Cerebral Palsy

NCT03402854
ACTIVE NOT RECRUITING NA

Home Based Tele-exercise for People With Chronic Neurological Impairments

NCT04564495
ACTIVE NOT RECRUITING Phase 2

Rehabilitation and Cortical Remodeling After Surgical Intervention for Spinal Cord Injury

NCT04041063
NOT YET RECRUITING Early Phase 1

Effects of Transcranial Random Noise Stimulation on Motor Learning in Typically Developing Adolescents

NCT06267339
TERMINATED NA

Reliability of Paired Associative Stimulation-induced Neuroplasticity After Stroke

NCT03861806
COMPLETED Phase 1

Home Exercise With Wearable Sensors

NCT03416842
COMPLETED Phase 3

Walkbot Robotic Training for Improvement in Gait

NCT03554642
COMPLETED Phase 3

Burke-Hocoma Efficiency Study

NCT03555825
COMPLETED Phase 2

Benfotiamine in Alzheimer's Disease: A Pilot Study

NCT02292238
COMPLETED NA

EEG Analytics to Determine Effectiveness of a tDCS Protocol

NCT03537885

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 2
Phase 3 2

Therapeutic Areas

Cerebral Palsy 3
Hemiparesis 2
Hemiplegia 2
Spinal Cord Injuries 2
Spastic Hemiplegic Cerebral Palsy 1
Spastic Hemiparesis 1
Spastic Cerebral Palsy 1
Trauma, Brain 1
Transverse Myelitis 1
Cervical Spinal Cord Injury 1

What is open in the Burke Medical Research Institute pipeline

2 recruiting of 11 indexed (18% open); 5 completed (45%).

Phase mix: 2 late (III/IV) vs 4 early (I/II) (early-phase heavy).

Top condition: Cerebral Palsy (3 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Burke Medical Research Institute: open-pipeline peers nationwide

Peers matched on 11 registered trials and 18% open enrollment, not the therapeutic-area sidebar.

Burke Medical Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 10152025 0%5%10%15%20% Total trials Recruiting share Burke Medical Research InstituteAderans Research InstituteAegerion PharmaceuticalsAllena PharmaceuticalsAOBiomeGrand Valley State UniversityImunonInventisBio Co.Kansas State University
Burke Medical Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Burke Medical Research Institute sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 11 trials (± recruiting share)

Sponsors near 18% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Burke Medical Research Institute page

11 registered trials is a research-attention snapshot, not an endorsement of Burke Medical Research Institute or any single study.

  • 2 of Burke Medical Research Institute's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Cerebral Palsy is the condition Burke Medical Research Institute studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Cerebral Palsy trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Burke Medical Research Institute pipeline card: 11 registered trials from official public datasets.Report a data error.